Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

715 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression.
Mourad G, Garrigue V, Squifflet JP, Besse T, Berthoux F, Alamartine E, Durand D, Rostaing L, Lang P, Baron C, Glotz D, Antoine C, Vialtel P, Romanet T, Lebranchu Y, Al Najjar A, Hiesse C, Potaux L, Merville P, Touraine JL, Lefrancois N, Kessler M, Renoult E, Pouteil-Noble C, Cahen R, Legendre C, Bedrossian J, Le Pogamp P, Rivalan J, Olmer M, Purgus R, Mignon F, Viron B, Charpentier B. Mourad G, et al. Among authors: baron c. Transplantation. 2001 Sep 27;72(6):1050-5. doi: 10.1097/00007890-200109270-00012. Transplantation. 2001. PMID: 11579299 Clinical Trial.
Rejection therapy with tacrolimus in renal transplantation: preliminary results of a collaborative multicenter study in 45 patients. Groupe Cooperatif de Transplantation D'ile de France (GCIF).
Maroun T, Aubert P, Baron C, Bedrossian J, Fornairon S, Lang P, Pruna A, Hiesse C. Maroun T, et al. Among authors: baron c. Transplant Proc. 1998 Sep;30(6):2811-2. doi: 10.1016/s0041-1345(98)00820-3. Transplant Proc. 1998. PMID: 9745576 Clinical Trial. No abstract available.
Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P. Grimbert P, et al. Among authors: baron c. Transpl Int. 2002 Nov;15(11):550-5. doi: 10.1007/s00147-002-0494-x. Epub 2002 Nov 8. Transpl Int. 2002. PMID: 12461659 Clinical Trial.
715 results